Skip to content
Technology
Pipeline
Overview
NS002 Epinephrine
NS001 Naloxone
About Us
News
Investors
Overview
Press Releases
Events
SEC Filings
Corporate Governance
Stock Information
FAQs
Contact
Technology
Pipeline
Overview
NS002 Epinephrine
NS001 Naloxone
About Us
News
Investors
Overview
Press Releases
Events
SEC Filings
Corporate Governance
Stock Information
FAQs
Contact
Nasus Pharma presented clinical results of intranasal epinephrine in EAACI
July 1, 2022
– July 3, 2022
European Academy of Allergy & Clinical Immunology (EAACI), July 1-3 2022, Prague
Download Presentation
View ALL Events
Scroll to Top
Secret Link